AMERICAN FOUNDATION FOR BIOLOGICAL… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1956

Legal Domicile

Principal Officer

EDWIN ASHOURIAN

Phone

3018813300

Tax Period

2025-01-01 to 2025-12-31

AMERICAN FOUNDATION FOR BIOLOGICAL RESEARCH, founded in 1956, is a community nonprofit that reported $6.9M in total revenue in fiscal year 2025. The organization ran a surplus of $1.4M, a strong 21% operating margin.

Mission

THE AMERICAN FOUNDATION FOR BIOLOGICAL RESEARCH (THE FOUNDATION) IS A NON- PROFIT ORGANIZATION INCORPORATED IN THE STATE OF ILLINOIS ON MARCH 16, 1948. THE BIOMEDICAL RESEARCH INSTITUTE WAS RECOGNIZED AS A TRADE NAME FOR THE FOUNDATION IN THE STATE OF MARYLAND IN MARCH 1994. THE FOUNDATION WAS ESTABLISHED WITH A MAJOR EMPHASIS ON CRYOBIOLOGY AND TROPICAL DISEASE RESEARCH. SCHISTOSOMIASIS, A MAJOR FOCUS AT THE FOUNDATION FOR MORE THAN 30 YEARS, IS A TROPICAL DISEASE THAT AFFECTS HUNDREDS OF MILLIONS OF PEOPLE IN SUB-SAHARAN AFRICA, PORTIONS OF SOUTH AMERICA AND PARTS OF RURAL ASIA. IN ADDITION TO BASIC SCHISTOSOMIASIS RESEARCH, THE FOUNDATION PROVIDES LIFE CYCLE STAGES OF SCHISTOSOMA PARASITES TO DOMESTIC AND INTERNATIONAL LABORATORIES, PRINCIPALLY THROUGH CONTRACTS WITH THE NATIONAL INSTITUTES OF HEALTH. THE FOUNDATION MAINTAINS THE FOLLOWING TWO MAJOR PROGRAM SERVICES: BIOREPOSITORY FACILITIES - THE FOUNDATION HOUSES A COLD STORAGE BIOSPECIMEN REPOSITORY WHICH SUPPORTS RESEARCH IN ACQ

Program Service Accomplishments

Program 1

Expenses: $3,978,856

THE FOUNDATION MAINTAINS THE FOLLOWING TWO MAJOR PROGRAM SERVICES: BIOREPOSITORY FACILITIES - THE FOUNDATION HOUSES A COLD STORAGE BIOSPECIMEN REPOSITORY WHICH SUPPORTS RESEARCH IN ACQUIRED...

THE FOUNDATION MAINTAINS THE FOLLOWING TWO MAJOR PROGRAM SERVICES: BIOREPOSITORY FACILITIES - THE FOUNDATION HOUSES A COLD STORAGE BIOSPECIMEN REPOSITORY WHICH SUPPORTS RESEARCH IN ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND OTHER CLINICALLY IMPORTANT DISEASES. SCHISTOSOMIASIS RESOURCE CENTER - PARASITE REAGENT PRODUCTION AND DISTRIBUTION AS WELL AS EDUCATION AND TRAINING ARE FOCUSED ON THE MAJOR TROPICAL DISEASE OF SCHISTOSOMIASIS. THE FOUNDATION PROVIDES LIFE STAGES OF SCHISTOSOMA PARASITES TO SCIENTISTS IN THE DOMESTIC AND INTERNATIONAL RESEARCH COMMUNITY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $6,123,189

Program Service Revenue $463,260

Investment Income $321,594

Other Revenue $12,445

TOTAL REVENUE $6,920,488

Expense Breakdown

Grants Paid $0

Salaries & Benefits $2,569,273

Fundraising Expenses $0

Program Expenses $3,978,856

Other Expenses $2,901,738

TOTAL EXPENSES $5,471,011

Year-over-Year Comparison

	2025	2024	Change
Revenue	$6,920,488	$7,001,788	0.0%
Expenses	$5,471,011	$5,953,541	-0.1%
Net Income	$1,449,477	$1,048,247	+0.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$446,508

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DR PHILIP LOVERDE	BOARD PRESID	1.00	Officer Director	$0	$0	$0
DR JOHN SACCI	BOARD VICE P	1.00	Officer Director	$0	$0	$0
BOB BURLESON	TREASUER	1.00	Officer Director	$0	$0	$0
RACHAEL WIDENER	DIRECTOR	1.00	Director	$0	$0	$0
CHRISTOPHER WHITE	DIRECTOR	1.00	Director	$0	$0	$0
BRIAN GAINES	DIRECTOR	1.00	Director	$0	$0	$0
JAY GEORGE	DIRECTOR	1.00	Director	$0	$0	$0
EDWIN ASHOURIAN	EXECUTIVE DI	40.00	Officer	$214,041	$23,771	$237,812
MARGARET MENTINK-KANE	CHIEF SCIENT	40.00	Officer	$186,784	$21,912	$208,696
ELENA H LIM	ACCOUNTING M	40.00	Highest	$106,681	$16,197	$122,878
ALEX FEDERLINE	BIOREPOSITOR	40.00	Highest	$103,739	$20,299	$124,038
DANIEL MACDONALD	BIOREPOSITOR	40.00	Highest	$100,343	$10,979	$111,322

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$6,920,488	$5,471,011	$21,389,959	$1,449,477
2024	$7,001,788	$5,953,541	$20,284,618	$1,048,247
2023	$6,032,932	$4,954,092	$19,464,077	$1,078,840
2022	$5,376,288	$4,496,527	$18,605,156	$879,761
2021	$4,727,292	$4,159,271	$13,124,832	$568,021
2020	$4,607,817	$4,011,291	$12,366,357	$596,526
2019	$4,946,962	$4,585,027	$11,633,615	$361,935
2018	$4,826,512	$4,602,427	$10,861,110	$224,085

AMERICAN FOUNDATION FOR BIOLOGICAL RESEARCH